Characteristics | No. | % |
---|---|---|
Age | ||
Median | 65 years | |
Range | 44–86 years | |
Gender | ||
Male | 72 | 80.9 |
Female | 17 | 19.1 |
Karnofsky performance status | ||
≧ 90 % | 72 | 80.9 |
< 90 % | 17 | 19.1 |
Location of tumor | ||
Cervix | 5 | 5.6 |
Upper thorax | 15 | 16.9 |
Middle thorax | 46 | 51.7 |
Lower thorax | 23 | 25.8 |
Clinical T stage | ||
cT1 | 22 | 24.7 |
cT2 | 7 | 7.9 |
cT3 | 34 | 38.2 |
cT4 | 26 | 29.2 |
Clinical N stage | ||
cN0 | 26 | 29.2 |
cN1 | 29 | 32.6 |
cN2 | 23 | 25.8 |
cN3 | 11 | 12.4 |
Clinical M stage | ||
cM0 | 81 | 91.0 |
cM1 | 8 | 9.0 |
Histology type | ||
Adenocarcinoma | 3 | 3.4 |
Squamous cell carcinoma | 86 | 96.6 |